US Blasts Cordis' Re-Exam Discovery Bid At Fed. Circ.
By Ryan Davis ( October 3, 2012, 4:35 PM EDT) -- The U.S. government told the Federal Circuit on Tuesday that the law is clear that discovery is not allowed in inter partes re-examination and urged the court to reject an argument by Johnson & Johnson's Cordis Corp. that it should be permitted to subpoena rival Abbott Laboratories in a re-examination of stent patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.